Successful treatment of a bifurcation lesion with the Carina Bard stent: A case report

Colombo, Antonio; Airoldi, Flavio; Sheiban, Imad; Mario, Carlo Di

doi:10.1002/(sici)1522-726x(199909)48:1<89::aid-ccd18>3.0.co;2-g

Cited by 12 publications

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The first bifurcated stents appeared in the 1990s, but their rigidity and poor profile were associated with a low rate of success. 10 As a consequence, the idea of treating the MB while protecting the SB with a single dedicated stent and delivery system emerged. The first controlled study with angiographic control during follow-up was carried out with the Multi-Link Frontier coronary bifurcation stent system (Guidant Corp., Santa Clara, CA, US).…”

Section: Figure 3: Bifurcation Lesion Classification and Distributionmentioning

confidence: 99%

Clinical and Procedural Evaluation of the Nile Croco® Dedicated Stent for Bifurcation – Six-month Clinical Follow-up Results of the Nile Croco Registry

Blanco¹,

Brenot²,

Royer³

et al. 2008

Interventional Cardiology Review

View full text Add to dashboard Cite

A true bifurcated lesion in coronary atherosclerotic disease is present in approximately 15% of patients referred for percutaneous coronary intervention (PCI). 1 The percutaneous approach to this especially complex scenario has been faced in many different ways depending on the techniques available at any particular time. [2][3][4] In the last few years, the introduction of drug-eluting stents (DES) has remarkably improved the outcome in bifurcation lesions compared with using baremetal stents (BMS), resulting in fewer adverse events and lower main branch (MB) restenosis rates. 5-7 However, the most suitable approach to the side branch (SB) remains uncertain. Although the initial 'provisional' stenting technique (i.e. stenting of the SB after MB stenting only in cases of suboptimal or inadequate result) is probably the prevailing approach, the four stent techniques that allow the stenting of both branches (i.e. crush, V, T, culottes) are appealing. However, even if the strategy of stenting both branches when the SB stenosis is suitable for stenting is promising, data in the literature indicate that clinical outcomes are

show abstract

Section: Figure 3: Bifurcation Lesion Classification and Distributionmentioning

confidence: 99%

Clinical and Procedural Evaluation of the Nile Croco® Dedicated Stent for Bifurcation – Six-month Clinical Follow-up Results of the Nile Croco Registry

Blanco¹,

Brenot²,

Royer³

et al. 2008

Interventional Cardiology Review

View full text Add to dashboard Cite

show abstract

“…Other techniques, such as placing ''kissing'' stents or fenestrating side holes in stents, have been used successfully at branching points, and some prototypical hinged stents are being marketed, but each of these techniques has distinctive disadvantages. [1][2][3] Although most reports are anecdotal, clinical sequelae of stenting over branch orifices include buttock claudication and even genital necrosis after covering the internal iliac artery. 4 Bifurcated stent-grafts for abdominal aortic aneurysms are manufactured by a number of medical device companies, but bifurcated stents for the treatment of bifurcational occlusive disease are not available.…”

mentioning

confidence: 99%